Portfolio

We back more than 40 Finnish technology companies. Around two thirds operate in the health, biotech and environmental technology sectors, in which Finnish innovation has worldwide relevance. Together, they represent a collection of ambitious companies building globally competitive solutions.

Many are now at a pivotal stage, with years of development behind them, commercial traction building and international expansion to come.

View portfolio
View exits

Growth companies in the Springvest portfolio

The view on this page reflects Springvest Corporation’s most recent financial report.

The companies that have most recently been in a funding round can be found on the investment platform.

Exits

Many of our portfolio companies have successfully grown to the next stage or found a new home through an acquisition or listing. For some, the journey has been cut short and operations have ended, which is a natural part of the demanding growth company landscape.

Acquired or publicly listed

1.5x

On average, investors have achieved approximately 1.5x returns at exit throughout Springvest’s history.

IRR 17%

Throughout Springvest’s history, investments have delivered an internal rate of return (IRR) of around 17%.

3.4 years

Throughout Springvest’s history, the average holding period of an investment has been approximately 3.4 years.

Other exits

Bankruptcies

  • Lynsight (2025)
  • Biomensio (2025)
  • MultiTaction (2022)
  • Biisafe (2022)
  • Medisapiens (2022)
  • Verto Analytics (2021)
  • ItsPure (2020)
  • Goodwiller (2020)
  • SignOn (2018)
  • Greenbiit (2015)
  • Neonella (2015)

Other exits

  • Fantastec
  • Linko (Inbot)
  • Minus Degree Mobile
  • Digital Fabric (Zadaa)
  • Ductor